Speaking Engagement Recap
Overview
Faegre Drinker Consulting principal Tim Franson joined a panel of pharmaceutical and regulatory leaders to discuss the outlook of drug development in 2025 at the 8th annual “Wow! Or Yeow 2025: FDA 2024 in Review.”
The panelists provided an overview of Food and Drug Administration (FDA) developments from the past year and look ahead to potential trends, and discussed the entire FDA regulatory landscape, from devices, digital technology, vaccines and nutritional products.